Global Dengue Vaccine Market Projected to Rise at a CAGR of 17.5% during the Forecast Period of 2017–2027

Rising burden of dengue fever in tropical regions, massive unmet medical need for managing dengue, development of live attenuated tetravalent dengue vaccine, and expected local production of dengue vaccine in several countries are expected to increase the demand for dengue vaccine in the global market. Considering this, Market Research Reports Search Engine (MRRSE) has recently publicized the addition of a new research report to its massive online collection with a title “Dengue Vaccine Market: Global Industry Analysis and Opportunity Assessment, 2017–2027”. The report is an in-depth and professional study of the current market state as well as the future prospects of the global dengue vaccine market.

Request for Sample Report: http://www.mrrse.com/sample/3038

The global dengue vaccine market is projected to grow at an impressive CAGR of 17.5% between 2017 and 2027. At this pace, the market is likely to reach a valuation of more than US$ 1250 million by the end of 2027 from US$ 250 million in 2017. The report starts with a market introduction followed by the global market overview of the dengue vaccine. One of the primary objectives of the report is to offer insights on the market dynamics which can influence the growth of the global dengue vaccine market during the forecast period. Details on key trends, drivers, restraints, risks, value forecasts and opportunities for companies operating in the dengue vaccine market are presented in the report. The report includes studies of the global dengue vaccine market in terms of market value (US$ Mn) and volume. It also studies various issues regarding the Dengvaxia, tiered pricing of dengue vaccine, pipeline assessment, sales channel strategy adoption, promotional activities of Sanofi, and epidemiology of dengue.

To make the report organized and easy to understand, the global dengue vaccine market is segregated based on the parameters such as product type, end-user and geographic region. On the basis of end-user, the global market is segmented into Hospitals, Government Institutes and Non-Governmental Organizations (NGOs). Based on geographic region, the segmentations are North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Middle East and Africa and Japan.

In the final section of the report, a competitive landscape analysis is provided to give a dashboard view of key companies operating in the global dengue vaccine market. This section is mainly intended to provide readers with an objective and detailed assessment of major providers specific to a market segment in the global dengue vaccine market. This section also provides market strategies and SWOT analysis of the key players operating in the global dengue vaccine market. Some of the key players profiled in the report are Sanofi and Takeda Pharmaceutical Company Limited.

Browse Full Report with TOC: http://www.mrrse.com/dengue-vaccines-market

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Follow Us on LinkedIn-https://www.linkedin.com/company/mrrse
Follow Us On Twitter-https://twitter.com/MRRSEmrrse

This release was published on openPR.